angiotensin ii has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arioka, M; Hosoda, H; Ishikane, S; Kitazono, T; Sasaguri, T; Takahashi-Yanaga, F; Takiguchi, T; Tetsuo, F | 1 |
1 other study(ies) available for angiotensin ii and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Angiotensin II promotes primary tumor growth and metastasis formation of murine TNBC 4T1 cells through the fibroblasts around cancer cells.
Topics: Angiotensin II; Animals; Cancer-Associated Fibroblasts; Cell Line, Tumor; Disease Models, Animal; Epithelial-Mesenchymal Transition; Female; Humans; Lung; Lung Neoplasms; Mammary Glands, Animal; Mice; Triple Negative Breast Neoplasms; Tumor Microenvironment | 2021 |